Sahraoui, Y <br/><br/>
Autocrine IL-2-dependent growth of a newly established CD3+, CD16-, CD56+, CD57+, J(H)-, TCRbeta-, TCRgamma- leukemia cell line (NOI-90).  [electronic resource] 

 -  Leukemia  Feb 1997 
 - 245-52 p.  digital 
<br/><br/> Publication Type: Case Reports; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0887-6924 
<br/><br/><label>Standard No.: </label>10.1038/sj.leu.2400562  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>CD3 Complex--analysis<br/>CD56 Antigen--analysis<br/>CD57 Antigens--analysis<br/>Culture Media, Conditioned--pharmacology<br/>Embryonal Carcinoma Stem Cells<br/>Fatal Outcome<br/>Fluorescent Antibody Technique, Indirect<br/>Gene Rearrangement<br/>Humans<br/>Immunoglobulin Heavy Chains--analysis<br/>Immunophenotyping<br/>Interleukin-2--pharmacology<br/>Male<br/>Middle Aged<br/>Neoplastic Stem Cells--drug effects<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--pathology<br/>Receptors, Antigen, T-Cell, alpha-beta--analysis<br/>Receptors, Antigen, T-Cell, gamma-delta--analysis<br/>Receptors, IgG--analysis<br/>Tumor Cells, Cultured